SANTA MONICA, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board:
CBAI -
News), the umbilical cord blood stem cell preservation company (
http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that CEO Matthew Schissler was interviewed by Francis Gaskins, a financial analyst, on the Company's future strategies, including improving its market cap.
The complete interview is available at
http://www.stoxrox.com/cbai-9-10-08.mp3 .
"We restructured our balance sheet in 2008 and significantly reduced debt. Our strategic plan is to grow dramatically in 2009 through organic growth, with our solid insurance channel, and to be aggressive in acquisitions, including internationally," Mr. Schissler said. He told Mr. Gaskins in the interview that any new acquisitions will be made only if the cash flow services the debt.
Cord Blood America's CEO also promised a more aggressive investor relations program in the coming weeks. He said the Company is researching closely storing other types of stem cells, including adipose tissue for cosmetic use, and a brand new stem cell storage model with a partner in the industry for families utilizing fertility clinics.
"Management remains very bullish on these strategies, the future of the Company, and our ability to increase our market cap," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
